Glucocorticoid use in acute respiratory failure from pulmonary causes and association with early changes in the systemic host immune response
Abstract Background Glucocorticoids are commonly used in patients with or at-risk for acute respiratory distress syndrome (ARDS), but optimal use remains unclear despite well-conducted clinical trials. We performed a secondary analysis in patients previously enrolled in the Acute Lung Injury and Bio...
Main Authors: | Nameer Al-Yousif, Seyed M. Nouraie, Matthew J. Broerman, Yingze Zhang, Tomeka L. Suber, John Evankovich, William G. Bain, Georgios D. Kitsios, Bryan J. McVerry, Faraaz A. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2024-03-01
|
Series: | Intensive Care Medicine Experimental |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40635-024-00605-y |
Similar Items
-
Serum metabolomic signatures of fatty acid oxidation defects differentiate host-response subphenotypes of acute respiratory distress syndrome
by: Tomeka L. Suber, et al.
Published: (2023-05-01) -
Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19
by: Juho Jalkanen, et al.
Published: (2023-03-01) -
Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis
by: Yazan Zayed, et al.
Published: (2020-06-01) -
Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy
by: Zhenli Zhu, et al.
Published: (2021-01-01) -
Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study
by: Qingbo Liao, et al.
Published: (2023-03-01)